Guangzhou LBP Medicine Science & Technology Co Ltd (688393) — Capital Reinvestment Ratio
Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥29.17 Million) in capital expenditures (CN¥12.17 Million). See 688393 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou LBP Medicine Science & Technology Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Guangzhou LBP Medicine Science & Technology Co Ltd's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Guangzhou LBP Medicine Science & Technology Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see Guangzhou LBP Medicine Science & Technol market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 6.67x | CN¥3.54 Million | CN¥23.65 Million | ▲ +202.7% |
| 2023 | 2.20x | CN¥17.12 Million | CN¥37.74 Million | ▼ -70.3% |
| 2022 | 7.43x | CN¥9.72 Million | CN¥72.17 Million | ▲ +208.9% |
| 2021 | 2.40x | CN¥59.61 Million | CN¥143.34 Million | ▲ +252.0% |
| 2020 | 0.68x | CN¥91.43 Million | CN¥62.45 Million | ▲ +72.5% |
| 2019 | 0.40x | CN¥89.74 Million | CN¥35.54 Million | ▼ -41.1% |
| 2018 | 0.67x | CN¥65.35 Million | CN¥43.92 Million | ▲ +68.7% |
| 2017 | 0.40x | CN¥83.92 Million | CN¥33.43 Million | ▲ +9.4% |
| 2016 | 0.36x | CN¥43.37 Million | CN¥15.79 Million | ▼ -88.5% |
| 2012 | 3.15x | CN¥4.84 Million | CN¥15.25 Million | — |